title: Value of pretransplantation cytokine profiles for predicting acute rejection in renal transplant recipients.
abstract: Episodes of acute rejection may represent an important risk factor for the development of chronic allograft nephropathy. Various studies have shown that pretransplant cytokine profiles in recipient blood are associated with transplant outcome. Serum samples were collected 24 hours before transplantation from 57 patients (38 men and 19 women of age 36 +/- 5 years) receiving kidneys from unrelated living donors. Additional samples were collected at 1 and 2 weeks after transplantation, as well as during every rejection episode. The immunosuppression consisted of a cyclosporine, prednisolone, and mycophenolate mofetil. Among the transplanted patients, 19 (33.3%) individuals experienced an acute rejection episode based on an increased level of serum creatinine and blood urea nitrogen during the first 14 days after transplantation. TGF-beta, IL-2 and IFN-gamma serum levels were determined by an ELISA method using Bindermed system kits. The mean concentration of TGF-beta before transplantation tended to be lower among patients with acute rejection episodes compared to those with stable graft (75,265 versus 85,394 pg/mL; P = .34) and at 1 week after transplantation (77,558 versus 84,390 pg/mL), although the differences were not significant. Among patients with rejection the mean IL-2 concentration was significantly higher before, at 1 week, and at 2 weeks after transplantation (15.0 versus 6.8 pg/mL, P = .005; 19.0 versus 4.9 pg/mL, P = .001; and 21.1 versus 4.7 pg/mL, P = .0001). The mean concentration of IFN-gamma was significantly higher pre- and at 1 and 2 weeks posttransplantation in patients with acute rejection episodes (161.1 versus 65.2, 175.6 versus 66.5 and 173.7 versus 77.1 pg/mL, all P < .001). In conclusion, evaluation of Th1 cytokines before transplantation may represent valuable predictive marker for an acute rejection episode.
authors.affiliation: Imam Khomeini Medical Center, Tehran, Iran.
authors.forename: M
authors.initials: M
authors.lastname: Lessan-Pezeshki
authors.forename: A
authors.initials: A
authors.lastname: Amirzargar
authors.forename: A
authors.initials: A
authors.lastname: Fathi
authors.forename: M R
authors.initials: MR
authors.lastname: Khatami
authors.forename: B
authors.initials: B
authors.lastname: Einollahi
authors.forename: V
authors.initials: V
authors.lastname: Pourfarziani
authors.forename: J
authors.initials: J
authors.lastname: Azmandian
authors.forename: F
authors.initials: F
authors.lastname: Khosravi
authors.forename: B
authors.initials: B
authors.lastname: Ansaripour
authors.forename: B
authors.initials: B
authors.lastname: Nikbin
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D016207:Cytokines / Q000097:blood*; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D007377:Interleukin-3 / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D011237:Predictive Value of Tests; D018417:Th1 Cells / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000097:blood
chemical_list: D015415:Biomarkers; D016207:Cytokines; D007377:Interleukin-3; D016212:Transforming Growth Factor beta; D007371:Interferon-gamma